Skip to main content

This job has expired

You will need to login before you can apply for a job.

Head of Investor Relations & Corporate Communications

Entrada Therapeutics
Boston, MA
Start date
Mar 21, 2024

View more

Marketing, Marketing/Corporate Communications
Required Education
Masters Degree/MBA
Position Type
Full time

Job Details

The Organization

What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.

Our Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA-, antibody- and enzyme-based programs for the potential treatment of neuromuscular, ocular, metabolic and immunological diseases, among others.

Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45 and 50 skipping amenable. We have also partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families.

The Perfect Addition to Our Team

We’re looking for a team member who is intellectually curious and can bring new ideas and perspectives to our growing team. Reporting to the Chief Corporate Affairs Officer, this individual will be a key connector across the organization, working with leaders and teammates alike.

The Opportunity

This role will be responsible for developing and implementing ambitious programs and communications to enhance our impact, visibility, and reputation as a change maker in biotech across multiple stakeholder groups. This will include:

  • Driving a broader understanding of intracellular therapeutics and appreciation for the potential of Entrada’s innovative platform and therapeutic pipeline.
  • Building and elevating Entrada’s visibility and profile as a clinical-stage biotech innovator.
  • Evolving Entrada’s differentiated positioning and value proposition.
  • Engaging and educating current and future colleagues on our mission, science and culture, continuing to grow and amplify our position as a Top Place to Work.
  • Develop and execute a strategic communication plan that encompasses investor relations, media relations, and corporate communications.
  • Manage financial communications, including earnings releases, investor presentations, and annual reports in close collaboration with both the finance and legal teams.
  • Build and maintain strong relationships with investors, analysts, and the financial community to enhance understanding and support for the Company's strategic direction and financial performance.
  • Collaborate with the executive team to ensure consistent messaging across all communication channels.
  • Lead the corporate social responsibility (CSR) initiatives and communication.
  • Monitor and analyze biopharmaceutical industry trends, investor perceptions, and competitor communications to inform strategic decisions.
  • Liaise with Patient Advocacy to drive disease awareness campaigns.
  • Work with human resources to drive internal communications that reinforce our corporate values.
  • Manage agency relationships and ensure efficiency in external spending.
  • Ability to travel 10-25% of the time, as dictated by the schedules of mandatory events and medical meetings.
The Necessities

At Entrada, our passion for science, our devotion to patients and our values drives our behavior:

  • Humanity - We genuinely care about patients and about one another.
  • Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients.
  • Creativity - We are creative problem solvers.
  • Collaboration - We are more than the sum of our parts.
  • Curiosity - We have a growth mindset and push conventional thought and theory.

To thrive on our team, you will need to come with:

  • Advanced scientific degree in relevant field.
  • 10 years of successful experience in corporate communication, investor relations, or a related field within the biotech or pharmaceutical industry.
  • Self-starter with excellent project management and organizational skills with the ability to prioritize multiple work streams and deadlines, balance opposing priorities, and communicate effectively.
  • Demonstrated ability to develop and execute communication strategies that effectively reach and influence target audiences.
  • Strong financial acumen and the ability to communicate complex financial information clearly.
  • Excellent written and verbal communication skills, with extreme attention to detail and a proven track record of serving as a company spokesperson.
  • Ability to work collaboratively across functions and with senior executives to achieve business objectives.
  • Deep understanding of the drug development process, and the regulatory and compliance environment in the biopharmaceutical industry.
The Perks

By becoming a team member here at Entrada, you’ll have access to competitive health, dental, and vision coverage, as well as life insurance, and short term and long-term disability insurance. We value work life balance, you'll benefit from discretionary time off, paternity leave, and an excellent 401(k) package. We also offer a generous transportation stipend to commute as you wish. Our location in the vibrant and growing Seaport District is close to all the best that the city of Boston has to offer.

Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.

Third Party Staffing Agencies

Entrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes.

Privacy Statement

Entrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement here to understand how and when your data is being used.


Entrada Therapeutics is a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicle (EEV™) therapeutics, to engage intracellular targets that have long been considered inaccessible and undruggable. The Company’s EEV therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues with an improved therapeutic index. Through its proprietary, highly versatile and modular EEV platform, Entrada is building a robust development portfolio of oligonucleotide-, antibody- and enzyme-based programs for the potential treatment of neuromuscular diseases, immunology, oncology and diseases of the central nervous system. The Company’s lead oligonucleotide programs include ENTR-601-44 targeting Duchenne muscular dystrophy (DMD) and ENTR-701 targeting myotonic dystrophy type 1 (DM1).

Stock Symbol: TRDA
Stock Exchange: NASDAQ



Company info
One Design Center Place Suite 17- 500

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert